These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 19336891

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes.
    Härtel C, Hammers HJ, Schlenke P, Fricke L, Schumacher N, Kirchner H, Müller-Steinhardt M.
    J Interferon Cytokine Res; 2003 Feb; 23(2):91-9. PubMed ID: 12744774
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A.
    Giese T, Zeier M, Schemmer P, Uhl W, Schoels M, Dengler T, Buechler M, Meuer S.
    Transplantation; 2004 Feb 15; 77(3):339-44. PubMed ID: 14966405
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal induced IL-2 mRNA monitoring in renal transplant patients immunosuppressed with cyclosporine and in unmodified canine renal transplant rejection.
    Zucker C, Zucker K, Asthana D, Carreno M, Viciana AL, Ruiz P, Esquenazi V, Nery J, Burke G, Miller J.
    Hum Immunol; 1996 Jan 15; 45(1):1-12. PubMed ID: 8655354
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased cyclosporin a sensitivity in vivo in pediatric renal transplant recipients compared with adults.
    Billing H, Sommerer C, Giese T, Zeier M, Meuer S, Czock D, Tönshoff B.
    Ther Drug Monit; 2012 Oct 15; 34(5):554-60. PubMed ID: 22929409
    [Abstract] [Full Text] [Related]

  • 11. Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin-2 production.
    van den Berg AP, Twilhaar WN, Mesander G, van Son WJ, van der Bij W, Klompmaker IJ, Slooff MJ, The TH, de Leij LH.
    Transplantation; 1998 Apr 27; 65(8):1066-71. PubMed ID: 9583867
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy.
    Roos K, Gotthardt D, Giese T, Schnitzler P, Stremmel W, Czock D, Eisenbach C.
    Liver Transpl; 2014 Sep 27; 20(9):1106-17. PubMed ID: 24890314
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporine A inhibits the mRNA expressions of IL-2, IL-4 and IFN-gamma, but not TNF-alpha, in canine mononuclear cells.
    Kobayashi T, Momoi Y, Iwasaki T.
    J Vet Med Sci; 2007 Sep 27; 69(9):887-92. PubMed ID: 17917372
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of inflammatory cytokine production in human corneal cells by dexamethasone, but not cyclosporin.
    Djalilian AR, Nagineni CN, Mahesh SP, Smith JA, Nussenblatt RB, Hooks JJ.
    Cornea; 2006 Jul 27; 25(6):709-14. PubMed ID: 17077666
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients: evaluation of long-term target C(2).
    Brunet M, Campistol JM, Millán O, Vidal E, Esforzado N, Rojo I, Jiménez O, Oppenheimer F, Corbella J, Martorell J.
    Int Immunopharmacol; 2003 Jul 27; 3(7):987-99. PubMed ID: 12810356
    [Abstract] [Full Text] [Related]

  • 16. Molecular monitoring of the immunosuppressive effects of cyclosporine in renal transplant patients by using a quantitative polymerase chain reaction.
    Koutouby R, Zucker C, Zucker K, Burke G, Nery J, Roth D, Esquenazi V, Miller J.
    Hum Immunol; 1993 Apr 27; 36(4):227-34. PubMed ID: 8340231
    [Abstract] [Full Text] [Related]

  • 17. Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-β, tumour necrosis factor-α and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients.
    Seyhun Y, Ciftci HS, Kekik C, Karadeniz MS, Tefik T, Nane I, Turkmen A, Oguz FS, Aydin F.
    Int J Immunogenet; 2015 Jun 27; 42(3):147-60. PubMed ID: 25817300
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H, Wynn C, Pan F, Ebbs A, Erickson LM, Kobayashi M.
    Transplantation; 2002 Jun 15; 73(11):1808-17. PubMed ID: 12085006
    [Abstract] [Full Text] [Related]

  • 19. Pretransplant pharmacodynamic analysis of immunosuppressive agents using CFSE-based T-cell proliferation assay.
    Kurata Y, Kato M, Kuzuya T, Miwa Y, Iwasaki K, Haneda M, Amioka K, Watarai Y, Uchida K, Nakao A, Kobayashi T.
    Clin Pharmacol Ther; 2009 Sep 15; 86(3):285-9. PubMed ID: 19404248
    [Abstract] [Full Text] [Related]

  • 20. New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations.
    Brunet M, Millán O, Jiménez O, Campistol JM, Vidal E, Rojo I, Oppenheimer F, Fortuna V, Martorell J.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):437S-441S. PubMed ID: 15041382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.